Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158736 · ClinicalTrials.gov registry record · NA
Genicular Nerve Block for Knee Pain in the ED
A NA study of Knee Pain, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 4
- Study locations
NCT07158736: Recruiting NA study of Knee Pain, sponsored by University of Pennsylvania.
NCT07158736 is a NA study of Knee Pain that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158736, a NA study of Knee Pain, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 4
- Study locations
Study Summary
Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.
Primary Outcome
Measured by numeric rating scale: 0 (minimum value) - 10 (maximum value)
Conditions Studied
Interventions
- OTHER Standard of Care
- PROCEDURE Genicular nerve block with bupivacaine and corticosteroids
Study Locations (4)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Pennsylvania Hospital - Philadelphia
- Pennsylvania Presbyterian Medical Center - Philadelphia
- HUP Cedar - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2025-08-06 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT07158736 shows while recruiting
NCT07158736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Knee Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT07158736 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07158736 about?
NCT07158736 is a clinical study titled "Genicular Nerve Block for Knee Pain in the ED". Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.
What is the current status of trial NCT07158736?
This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2025-08-06. Estimated completion is 2026-09-01.
What conditions does trial NCT07158736 study?
This clinical trial studies the following conditions: Knee Pain.
What interventions are being tested in trial NCT07158736?
The interventions under investigation include: Standard of Care (OTHER), Genicular nerve block with bupivacaine and corticosteroids (PROCEDURE).
Who is sponsoring clinical trial NCT07158736?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07158736 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07158736's enrollment target sits among peer trials
34 1571st of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI